Business article - August 27, 2026
Episurf Medical to wind down medtech business
Episurf Medical has concluded the strategic review of its medtech operations and will now pursue an orderly wind-down of that business, accelerating its transformation into a pure-play Nordic property company.
Business article - August 25, 2026
Q&A: Simon Fredriksson, CEO and Co-founder, Pixelgen
NLS asked the CEO and co-founder of Pixelgen about entrepreneurship in Sweden, the company's global commercialization strategy and the most exciting clinical applications of the company's Proxiome kit.
Business article - August 17, 2026
Evaxion expands and refocuses R&D pipeline
Evaxion expands it pipeline of cancer vaccine programs with EVX-05 against the deadly brain cancer glioblastoma.
Business article - August 2, 2026
UK’s biotech pulse is picking up again
After an “incredibly difficult time”, the life science industry in the UK is showing clear signs of renewed momentum as venture capital is edging upward and activity across the ecosystem is intensifying.
Business article - July 24, 2026
BII announces new initiative to accelerate drug discovery for cardiometabolic diseases
The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for cardiometabolic diseases (CMDs).
Business article - June 29, 2026
“Our goal is to build a European framework that matches our scientific excellence with competitive financing capacity”
NLS asked Cedric Moreau, Chair of the Oversight Committee of the European Life Sciences Coalition (ELSC) and Partner at VC firm Sofinnova Partners, about the future of life sciences innovation and investment in Europe.
